Literature DB >> 19018007

Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells.

Sandeep Krishnan1, Yuang-Taung Juang, Bhabadeb Chowdhury, Abigail Magilavy, Carolyn U Fisher, Hang Nguyen, Madhusoodana P Nambiar, Vasileios Kyttaris, Arthur Weinstein, Rena Bahjat, Polly Pine, Violeta Rus, George C Tsokos.   

Abstract

Diminished expression of TCR zeta and reciprocal up-regulation and association of FcRgamma with the TCR/CD3 complex is a hallmark of systemic lupus erythematosus (SLE) T cells. In this study we explored whether differential molecular associations of the spleen tyrosine kinase Syk that preferentially binds to FcRgamma contribute to pathological amplification of signals downstream of this "rewired TCR" in SLE. We detected higher amounts of Syk expression and activity in SLE compared with normal T cells. Selective inhibition of the activity of Syk reduced the strength of TCR-induced calcium responses and slowed the rapid kinetics of actin polymerization exclusively in SLE T cells. Syk and ZAP-70 also associated differently with key molecules involved in cytoskeletal and calcium signaling in SLE T cells. Thus, while Vav-1 and LAT preferentially bound to Syk, phospholipase C-gamma1 bound to both Syk and ZAP-70. Our results show that differential associations of Syk family kinases contribute to the enhanced TCR-induced signaling responses in SLE T cells. Thus, we propose molecular targeting of Syk as a measure to control abnormal T cell responses in SLE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19018007      PMCID: PMC2586973          DOI: 10.4049/jimmunol.181.11.8145

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

Review 1.  T cell antigen-receptor signal transduction.

Authors:  J E van Leeuwen; L E Samelson
Journal:  Curr Opin Immunol       Date:  1999-06       Impact factor: 7.486

Review 2.  The Syk family of protein tyrosine kinases in T-cell activation and development.

Authors:  D H Chu; C T Morita; A Weiss
Journal:  Immunol Rev       Date:  1998-10       Impact factor: 12.988

3.  Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression.

Authors:  L A Timmerman; N A Clipstone; S N Ho; J P Northrop; G R Crabtree
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

4.  Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction.

Authors:  L J Holsinger; I A Graef; W Swat; T Chi; D M Bautista; L Davidson; R S Lewis; F W Alt; G R Crabtree
Journal:  Curr Biol       Date:  1998-05-07       Impact factor: 10.834

5.  Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor.

Authors:  K D Fischer; Y Y Kong; H Nishina; K Tedford; L E Marengère; I Kozieradzki; T Sasaki; M Starr; G Chan; S Gardener; M P Nghiem; D Bouchard; M Barbacid; A Bernstein; J M Penninger
Journal:  Curr Biol       Date:  1998-05-07       Impact factor: 10.834

6.  Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product.

Authors:  P Crespo; K E Schuebel; A A Ostrom; J S Gutkind; X R Bustelo
Journal:  Nature       Date:  1997-01-09       Impact factor: 49.962

7.  Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain.

Authors:  S N Liossis; X Z Ding; G J Dennis; G C Tsokos
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

8.  Inhibition of mast cell Fc epsilon R1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol.

Authors:  J M Oliver; D L Burg; B S Wilson; J L McLaughlin; R L Geahlen
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

9.  Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling.

Authors:  A C Chan; N S van Oers; A Tran; L Turka; C L Law; J C Ryan; E A Clark; A Weiss
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

10.  LAT is required for TCR-mediated activation of PLCgamma1 and the Ras pathway.

Authors:  T S Finco; T Kadlecek; W Zhang; L E Samelson; A Weiss
Journal:  Immunity       Date:  1998-11       Impact factor: 31.745

View more
  48 in total

Review 1.  T cells as therapeutic targets in SLE.

Authors:  José C Crispín; Vasileios C Kyttaris; Cox Terhorst; George C Tsokos
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

2.  Altered BCR signalling quality predisposes to autoimmune disease and a pre-diabetic state.

Authors:  Sebastian Königsberger; Jan Prodöhl; David Stegner; Vanessa Weis; Martin Andreas; Martin Stehling; Theresa Schumacher; Ruben Böhmer; Ina Thielmann; Judith M M van Eeuwijk; Bernhard Nieswandt; Friedemann Kiefer
Journal:  EMBO J       Date:  2012-06-22       Impact factor: 11.598

Review 3.  Tyrosine kinases in inflammatory dermatologic disease.

Authors:  Ricardo T Paniagua; David F Fiorentino; Lorinda Chung; William H Robinson
Journal:  J Am Acad Dermatol       Date:  2010-06-26       Impact factor: 11.527

4.  CREMα suppresses spleen tyrosine kinase expression in normal but not systemic lupus erythematosus T cells.

Authors:  Debjani Ghosh; Katalin Kis-Toth; Yuang-Taung Juang; George C Tsokos
Journal:  Arthritis Rheum       Date:  2012-03

Review 5.  PSGL-1: A New Player in the Immune Checkpoint Landscape.

Authors:  Roberto Tinoco; Dennis C Otero; Amy A Takahashi; Linda M Bradley
Journal:  Trends Immunol       Date:  2017-03-02       Impact factor: 16.687

Review 6.  Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.

Authors:  Andras Perl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

7.  Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines.

Authors:  R A Wilcox; D X Sun; A Novak; A Dogan; S M Ansell; A L Feldman
Journal:  Leukemia       Date:  2009-09-24       Impact factor: 11.528

8.  Lipids rule: resetting lipid metabolism restores T cell function in systemic lupus erythematosus.

Authors:  Yoko Kidani; Steven J Bensinger
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

9.  Tyrosine phosphorylation of 3BP2 regulates B cell receptor-mediated activation of NFAT.

Authors:  Upasana Shukla; Tomoko Hatani; Kenji Nakashima; Kazuhiro Ogi; Kiyonao Sada
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

10.  Gene network analysis of bone marrow mononuclear cells reveals activation of multiple kinase pathways in human systemic lupus erythematosus.

Authors:  Magdalene Nakou; George Bertsias; Ilias Stagakis; Michael Centola; Ioannis Tassiulas; Maria Hatziapostolou; Iraklis Kritikos; George Goulielmos; Dimitrios T Boumpas; Dimitrios Iliopoulos
Journal:  PLoS One       Date:  2010-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.